Literature DB >> 12008653

Laryngeal chondroma.

Ramon A Franco1, Bhuvanesh Singh, Gady Har-El.   

Abstract

Cartilaginous tumors of the larynx represent less than 1% of laryngeal tumors. Chondroma and "low-grade" chondrosarcoma are the most common; 70%-75% of these tumors arise on the endolaryngeal surface of the posterior lamina of the cricoid cartilage. The clinical presentation is varied and directly dependent on the size and location of the tumor; stridor, hoarseness, dyspnea, or a neck mass are common presenting signs. CT scanning in the axial plane is the mainstay of radiographic imaging due to its ability to show size, extent of the tumor, and invasion into surrounding structures. Surgical extirpation is the standard therapy with no role for radiation therapy or chemotherapy. Although significant recurrence rates have been reported, there is not a significant difference between initial conservative therapy followed by salvage therapy versus initial radical therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12008653     DOI: 10.1016/s0892-1997(02)00077-2

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  4 in total

Review 1.  Evaluation of the patient with hoarseness.

Authors:  A Van der Goten
Journal:  Eur Radiol       Date:  2004-04-14       Impact factor: 5.315

2.  Laryngeal chondroma presenting as a laryngopyocele.

Authors:  Irfan Papila; Engin Acioğlu; Emin Karaman; Canan Akman
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-11-11       Impact factor: 2.503

3.  Laryngeal chondroma: a rare diagnosis in this localization.

Authors:  Ebru Tastekin; Semsi Altaner; Cem Uzun; Ahmet R Karasalihoglu; Cigdem Ozdemir; Ali Kemal Kutlu
Journal:  Case Rep Pathol       Date:  2011-11-30

4.  Chondroma of laryngeal cartilage mimicking thyroid tumor: A case report.

Authors:  ZiQiao Tan; Mengwei Yao; Tao Liu; Shaohua Wang; Jing Xu; Yonghong Zhang; Xinxin Yang; Dengdian Ma; Xiaoyu Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.